Series B - Confluence Life Sciences
Investment Firm
Overview
Confluence Life Sciences is focused on rational drug designs to develop novel kinase inhibitors for use in human and animal healthcare.
Announced Date
Jul 28, 2015
Funding Type
Series B
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
5
Round Details and Background
Confluence Life Sciences raised $2400000 on 2015-07-28 in Series B
Confluence Life Sciences is focused on rational drug designs to develop novel kinase inhibitors for use in human and animal healthcare.
Company Funding History
7
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Oct 24, 2013 |  Series A - Confluence Life Sciences | 1 | - | 500.0K |
| Apr 01, 2011 | Seed Round - Confluence Life Sciences | 1 | - | 75.0K |
| Jul 11, 2012 | Seed Round - Confluence Life Sciences | - | 895.0K | |
| Sep 17, 2012 | Series A - Confluence Life Sciences | 3 | - | 4.0M |
Recent Activity
There is no recent news or activity for this profile.